These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of size and temperature at vaccination on immunization and protection conferred by a live attenuated Francisella noatunensis immersion vaccine in red hybrid tilapia. Soto E; Brown N; Gardenfors ZO; Yount S; Revan F; Francis S; Kearney MT; Camus A Fish Shellfish Immunol; 2014 Dec; 41(2):593-9. PubMed ID: 25462454 [TBL] [Abstract][Full Text] [Related]
3. Francisella noatunensis subspecies noatunensis clpB deletion mutant impairs development of francisellosis in a zebrafish model. Lampe EO; Zingmark C; Tandberg JI; Thrane IMP; Brudal E; Sjöstedt A; Winther-Larsen HC Vaccine; 2017 Dec; 35(52):7264-7272. PubMed ID: 29153776 [TBL] [Abstract][Full Text] [Related]
5. Development of IglC and GroEL recombinant vaccines for francisellosis in Nile tilapia, Oreochromis niloticus. Shahin K; Pirezan F; Rogge M; LaFrentz BR; Shrestha RP; Hildebrand M; Lu F; HogenEsch H; Soto E Fish Shellfish Immunol; 2020 Oct; 105():341-349. PubMed ID: 32712230 [TBL] [Abstract][Full Text] [Related]
6. Francisella noatunensis subsp. orientalis pathogenesis analyzed by experimental immersion challenge in Nile tilapia, Oreochromis niloticus (L.). Soto E; Kidd S; Mendez S; Marancik D; Revan F; Hiltchie D; Camus A Vet Microbiol; 2013 May; 164(1-2):77-84. PubMed ID: 23415477 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of an inactivated whole-cell injection vaccine for nile tilapia, Oreochromis niloticus (L), against multiple isolates of Francisella noatunensis subsp. orientalis from diverse geographical regions. Shahin K; Shinn AP; Metselaar M; Ramirez-Paredes JG; Monaghan SJ; Thompson KD; Hoare R; Adams A Fish Shellfish Immunol; 2019 Jun; 89():217-227. PubMed ID: 30951851 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Francisella orientalis ΔpdpA as a Live Attenuated Vaccine against Piscine Francisellosis in Nile Tilapia. de Alexandre Sebastião F; Hansen JD; Soto E J Aquat Anim Health; 2022 Sep; 34(3):134-139. PubMed ID: 35997232 [TBL] [Abstract][Full Text] [Related]
9. Development and efficacy of a novobiocin-resistant Streptococcus iniae as a novel vaccine in Nile tilapia (Oreochromis niloticus). Pridgeon JW; Klesius PH Vaccine; 2011 Aug; 29(35):5986-93. PubMed ID: 21708205 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration. Evans JJ; Klesius PH; Shoemaker CA Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858 [TBL] [Abstract][Full Text] [Related]
11. Potential use of a transposon Tn916-generated mutant of Aeromonas hydrophila J-1 defective in some exoproducts as a live attenuated vaccine. Liu Y; Bi Z Prev Vet Med; 2007 Jan; 78(1):79-84. PubMed ID: 17079040 [TBL] [Abstract][Full Text] [Related]
12. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Pammit MA; Raulie EK; Lauriano CM; Klose KE; Arulanandam BP Infect Immun; 2006 Apr; 74(4):2063-71. PubMed ID: 16552035 [TBL] [Abstract][Full Text] [Related]
13. Development and efficacy of novobiocin and rifampicin-resistant Aeromonas hydrophila as novel vaccines in channel catfish and Nile tilapia. Pridgeon JW; Klesius PH Vaccine; 2011 Oct; 29(45):7896-904. PubMed ID: 21872628 [TBL] [Abstract][Full Text] [Related]
14. Passive immunization of Nile tilapia (Oreochromis niloticus) provides significant protection against Streptococcus agalactiae. Pasnik DJ; Evans JJ; Klesius PH Fish Shellfish Immunol; 2006 Oct; 21(4):365-71. PubMed ID: 16531069 [TBL] [Abstract][Full Text] [Related]
15. Development of an inactivated whole cell vaccine through immersion for immunoprophylaxis of Francisella orientalis infections in Nile tilapia (Oreochromis niloticus L.) fingerlings and juveniles. Oliveira TF; Quieróz GA; Leibowitz MP; Gomes Leal CA Fish Shellfish Immunol; 2022 Aug; 127():405-411. PubMed ID: 35772679 [TBL] [Abstract][Full Text] [Related]
16. Interaction of Francisella noatunensis subsp. orientalis with Oreochromis mossambicus bulbus arteriosus cell line. Soto E; Yun S; Lewis J; Kearney MT; Hansen J Microb Pathog; 2017 Apr; 105():326-333. PubMed ID: 28286149 [TBL] [Abstract][Full Text] [Related]
17. Francisella asiatica as the causative agent of piscine francisellosis in cultured tilapia (Oreochromis sp.) in the United States. Soto E; Baumgartner W; Wiles J; Hawke JP J Vet Diagn Invest; 2011 Jul; 23(4):821-5. PubMed ID: 21908332 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of the fish pathogen Francisella sp. by mutation of the iglC* gene. Soto E; Fernandez D; Hawke JP J Aquat Anim Health; 2009 Sep; 21(3):140-9. PubMed ID: 20043398 [TBL] [Abstract][Full Text] [Related]
19. Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro. Li LP; Wang R; Liang WW; Huang T; Huang Y; Luo FG; Lei AY; Chen M; Gan X Fish Shellfish Immunol; 2015 Aug; 45(2):955-63. PubMed ID: 26087276 [TBL] [Abstract][Full Text] [Related]
20. Characterization and Vaccine Potential of Membrane Vesicles Produced by Francisella noatunensis subsp. orientalis in an Adult Zebrafish Model. Lagos L; Tandberg JI; Repnik U; Boysen P; Ropstad E; Varkey D; Paulsen IT; Winther-Larsen HC Clin Vaccine Immunol; 2017 May; 24(5):. PubMed ID: 28331079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]